Ashfield is delighted to announce that we are now members of the National Clinical Homecare Association (NCHA), an organisation representing companies that provide clinical homecare services to patients in the UK.
NCHA members seek to provide patient-centred homecare services that are safe, cost effective and ensure seamless, integrated patient care. The NCHA promotes a level playing field and open industry standards to support the growth of the homecare market and the provision of high quality services to homecare patients.
The UK Homecare market value is estimated at £2.1bn and is relentlessly growing at over 20% year on year. The share of the secondary care medicines budget would rise to 60% if extended to all medicines known to be suitable for homecare. Given the choice, many patients choose to be treated at home rather than in hospital, and 275,000 patients already receive clinical homecare services*.
The NHS Five-year-forward and Carter review anticipate the further extension of clinical homecare services to treat patients in community settings. The NCHA works with the National Homecare Medicines Committee, regulators and other stakeholders to ensure that all appropriate patients are able to benefit from safe, high quality, pharma or NHS funded clinical homecare services.
Anita Osborn, Clinical Services Director at Ashfield, commented, “I’m delighted that we will be able to contribute to the vision and outcomes that this important industry group is developing as we continue to evolve our Clinical Services”.
Ashfield Clinical is a leading provider of innovative, flexible and scalable Patient Support Programmes, with over 15 years’ experience in designing and delivering a wide range of programmes. Clinical services include patient adherence, multichannel engagement, educational content and tailored care plans. Ashfield supports pharmaceutical and healthcare companies across a large number of therapy areas, including rare conditions.